Napoli Shkolnik Applauds U.S. Supreme Court Decision to Reject Liability Shield at Center of Purdue Pharma Settlement; Will Pursue Litigation Against Sacklers [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Supreme Court's decision today to reject the liability shield at the center of Purdue Pharma's settlement. The liability shield would have protected members of the Sackler family from civil claims related to the opioid epidemic. Napoli Shkolnik sued the Sacklers in 2018, as part of their ground-breaking Nassau County case against several pharmaceutical companies. Their case against the Sacklers could not go to trial because of the shield of bankruptcy. Now, their litigation against them can proceed. In 2021, a jury found Teva Pharmaceuticals and five other companies responsible for causing a public nuisance in Nassau County by minimizing the addictiveness of opioids with misleading marketing. The Napoli Shkolnik trial team included Partners Hunter Shkolnik, Salvatore C. Badala, Joseph L. Ciaccio, and Shayna E. Sacks. In 2022, Napoli Shkolnik and their partners reached an agreement with opioid manufacturers Teva and AbbVie to structure a combined $6 billion settlement paid direct
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses [Yahoo! Finance]Yahoo! Finance
- New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment PausesBusiness Wire
- Public advisory - One lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion recalled due to an impurity that may pose health risks [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Jefferies Financial Group Inc. from $19.00 to $23.00. They now have a "buy" rating on the stock.MarketBeat
- Cystic Fibrosis (CF) Therapeutics Global Market Research Report 2024: Burgeoning Emphasis on Personalized Medicine and Targeted Therapies - Long-term Forecasts to 2028 and 2033 [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 5/8/24 - Miss
TEVA
Sec Filings
- 6/25/24 - Form 8-K
- 6/21/24 - Form 4
- 6/18/24 - Form 144
- TEVA's page on the SEC website